Loading...
XHKG
8037
Market cap116mUSD
Dec 05, Last price  
0.93HKD
1D
3.33%
1Q
-7.92%
Jan 2017
158.33%
IPO
-95.20%
Name

China Biotech Services Holdings Ltd

Chart & Performance

D1W1MN
XHKG:8037 chart
P/E
—
P/S
12.84
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.16%
Rev. gr., 5y
3.55%
Revenues
71m
-66.74%
197,457,000243,386,000270,753,000272,277,000160,522,00084,184,00045,017,000101,354,00085,300,000140,385,00034,127,00086,565,000105,135,00070,304,00059,214,000655,792,000623,761,0001,851,532,000211,985,00070,509,000
Net income
-198m
L+107.60%
25,165,000528,000-38,333,000-37,425,000-83,561,000-16,465,000-43,555,000-20,698,000-60,231,200-82,929,000-62,269,000-50,151,000-63,022,000-64,250,000-107,483,000167,623,000132,572,000705,568,000-95,447,000-198,146,000
CFO
-152m
L
18,596,00022,720,000-18,547,000-20,636,0008,362,000-1,508,000-27,020,000-1,574,000-41,720,000-40,011,000-85,123,000-25,392,000-56,951,000-14,759,000-30,306,000421,999,00040,505,000482,748,000195,193,000-151,890,000
Dividend
May 19, 20230.01 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

China Biotech Services Holdings Limited, an investment holding company, provides medical laboratory testing and health check services in the People's Republic of China and Hong Kong. The company operates through five segments: Immunotherapy, Pharmaceutical Products, Medical and Health Related Services, Securities, Insurance brokerage, and Others segments. It also engages in the research, development, manufacture, sale, and distribution of health related and pharmaceutical products; trading of securities; money lending business; provision of tumor immune cell therapy, immune cell storage, and health management services; and provision of coordination of healthcare providers services. In addition, the company markets and sells health supplements, slimming pills, Chinese medicines, and beauty products; trades in pharmaceutical intermediates; and offers insurance brokerage services. Further, it provides property investment and logistic services. The company was formerly known as Rui Kang Pharmaceutical Group Investments Limited and changed its name to China Biotech Services Holdings Limited in November 2017. China Biotech Services Holdings Limited was founded in 1996 and is headquartered in Causeway Bay, Hong Kong.
URL
http://www.cbshhk.com/
IPO date
Jun 17, 2004
Employees
187
Domiciled in
HK
Incorporated in
BM

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT